Biogen Inc. (BIIB) Q4 FY25 Earnings Call

Growth products and pipeline catalysts are advancing, but 2026 revenue remains pressured by accelerating legacy-MS erosion.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-07
Length64 minutes
EPS$1.99
EPS consensus$1.61
Revenue$2.3B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q1 FY26 · Q3 FY25 · Q2 FY25 · Q1 FY25 · Q4 FY24

Read the full Q4 FY25 earnings call transcript

All BIIB earnings · Back to BIIB overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.